ProCE Banner Activity

Diagnosis and Management of aTTP: An Expert’s Review of Current Clinical Practice

Clinical Thought
Read this commentary from expert hematologist Paul Coppo, MD, on the current approach for diagnosis and management of aTTP using current International Society on Thrombosis and Haemostasis guidelines, actionable biomarkers, and targeted therapies.

Released: October 21, 2021

Expiration: October 20, 2022

Share

Faculty

Paul Coppo

Paul Coppo, MD, PhD

Professor of Hematology
Sorbonne University
Doctor of Hematology, AP-HP
Paris, France

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Sanofi Genzyme

Faculty Disclosure

Primary Author

Paul Coppo, MD, PhD

Professor of Hematology
Sorbonne University
Doctor of Hematology, AP-HP
Paris, France

Paul Coppo, MD, has disclosed that he has received consulting fees from Alexion Pharmaceuticals, Octapharma AG, Roche, Sanofi Aventis , Sanofi, and Takeda and fees for non-CME/CE services from Alexion Pharmaceuticals, Roche, Sandoz, Sanofi Aventis, and Takeda.